Tuesday, November 12, 2019

Journals on Emergency Medicine - BJSTR Journal

Abstract

Left ventricular assist device (LVAD) is a strong #therapeutic tool to improve survival in patients with advanced heart failure, whereas not a few patients have potentially abnormal #hemodynamics despite LVAD supports. #Hemodynamic ramp test, which is recently proposed to undergo following LVAD implantation, is a promising procedure to predict patient clinical outcome by assessing hemodynamic profile and to improve patients’ prognosis by optimizing hemodynamics via LVAD speed adjustment. Further prospective randomized control trial is warranted to clearly demonstrate clinical implication of the ramp test. Owing to the improvement of device technology, more sophisticated management protocol, and #cumulating clinical knowledge, actual survival for the patients with advanced heart failure (HF) receiving left #ventricular assist device (LVAD) improved dramatically during the recent several decades (Figure 1) [1]. Nevertheless, the rates of re-admission due to device-related #comorbidities remain high and unsolved issues thus far [2]. 

For more articles on BJSTR Journal please click on https://biomedres.us/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Types and Treatments of Leishmaniasis

  Types and Treatments of Leishmaniasis Introduction The Leishmaniasis are a cluster of parasitic diseases produced by morphologically alike...